×
Close
Sign Up
Login
Home
Library S
Library D
Events & Partner
WeMed
MDLA Events Platform
Events
Media Partners
Educational Partner
User Tools
FAQ/USER GUIDE
Language
English
中文/ Chinese
French
Português
Español
Arabic
Russian
Contact Us
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
Categories
Hematology
5598
Global Medical University
5169
Allergy
1797
Anatomy & Morphology
1584
Andrology
379
Anesthesia & Intensive Care
1282
Anesthesiology
5456
Audiology & Speech-Language Pathology
347
Behavioral Sciences
100
Biochemical Research Methods
7129
Biochemistry & Molecular Biology
29964
Biodiversity Conservation
345
Biology
8446
Biophysics
8229
Biotechnology & Applied Microbiology
8602
Cardiac & Cardiovascular Systems
31023
Cardiovascular & Respiratory Systems
1381
Cell & Tissue Engineering
696
Cell Biology
11195
Chemistry, Analytical
4293
Chemistry, Applied
10903
Chemistry, Medicinal
8728
Chemistry, Multidisciplinary
18516
Clinical Immunology & Infectious Disease
454
Clinical Medicine
8949
Clinical Neurology
16596
Clinical Psychology & Psychiatry
1309
Critical Care Medicine
3193
Dentistry, Oral Surgery & Medicine
13492
Dermatology
7467
Developmental Biology
6899
Ecology
643
Education, Scientific Disciplines
2067
Emergency Medicine
4081
Endocrinology, Metabolism & Nutrition
24452
Engineering, Biomedical
3750
Entomology
450
Environmental Medicine & Public Health
4715
Evolutionary Biology
268
Gastroenterology & Hepatology
12194
General & Internal Medicine
6958
Genetics & Heredity
15063
Geriatrics & Gerontology
5126
Gerontology
369
Health Care Sciences & Services
16177
Health Policy & Services
649
Immunology
24695
Infectious Diseases
13982
Integrative & Complementary Medicine
2934
Medical Ethics
1230
Medical Informatics
2270
Medical Laboratory Technology
419
Medicine, General & Internal
44236
Medicine, Legal
532
Medicine, Research & Experimental
17733
Microbiology
23270
Mycology
0
Nanoscience & Nanotechnology
5454
Neuroimaging
1395
Neurology
4546
Neurosciences
39652
Nursing
9694
Nutrition & Dietetics
7854
Obstetrics & Gynecology
8286
Oncology
52188
Ophthalmology
9705
Optics
4283
Orthopedics
11773
Orthopedics, Rehabilitation & Sports Medicine
1799
Otolaryngology
1590
Otorhinolaryngology
4862
Parasitology
1138
Pathology
5141
Pediatrics
21657
Peripheral Vascular Disease
4823
Pharmacology & Pharmacy
35311
Pharmacology/Toxicology
12080
Physiology
8870
Polymer Science
533
Primary Health Care
870
Psychiatry
19047
Psychology
5209
Psychology, Applied
112
Psychology, Biological
388
Psychology, Clinical
811
Psychology, Developmental
244
Psychology, Educational
169
Psychology, Experimental
166
Psychology, Mathematical
0
Psychology, Multidisciplinary
1688
Psychology, Psychoanalysis
30
Psychology, Social
119
Public Health & Health Care Science
2246
Public, Environmental & Occupational Health
27064
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12394
Radiology, Nuclear Medicine & Medical Imaging
8088
Rehabilitation
3048
Remote Sensing
0
Reproductive Biology
2852
Reproductive Medicine
1196
Research/Laboratory Medicine & Medical Technology
3967
Respiratory System
7406
Rheumatology
6039
Social Sciences, Biomedical
1196
Substance Abuse
2751
Surgery
33760
Toxicology
4445
Transplantation
948
Tropical Medicine
300
Urology & Nephrology
13014
Veterinary Sciences
35
Virology
2501
Zoology
0
Channels
BLOOD CANCER JOURNAL
466
Hematology\Oncology
3
Medrxiv - Hematology
233
AMERICAN JOURNAL OF HEMATOLOGY
236
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
40
BRITISH JOURNAL OF HAEMATOLOGY
458
CIRCULATION RESEARCH
363
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
547
HAEMOPHILIA
130
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
241
LANCET HAEMATOLOGY
13
THERAPEUTIC ADVANCES IN HEMATOLOGY
26
ACTA HAEMATOLOGICA
155
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
164
BLOOD COAGULATION & FIBRINOLYSIS
66
BLOOD PURIFICATION
183
CURRENT OPINION IN HEMATOLOGY
43
EUROPEAN JOURNAL OF HAEMATOLOGY
95
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
228
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
226
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
373
HEMATOLOGY REPORTS
14
IRAQI JOURNAL OF HEMATOLOGY
88
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
120
INTERNATIONAL JOURNAL OF HEMATOLOGY
578
JOURNAL OF HEMATOPATHOLOGY
166
SCI Abstract
search
ALL
RECOMMENDED
+
18F-FDG brain/cerebellum-to-liver ratios as prognostic factors
We read with great interest the article by Dingli et al. [1] in which they study the ratio of brain to liver 18F-FDG uptak...
Blood Cancer Journal
comment
0
thumb_up
0
Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy
Cytogenetic aberrations remain a cornerstone of AML classification, prognost...
Blood Cancer Journal
comment
0
thumb_up
0
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
Competing interests Mark D. Ewalt has received speaking fees from Pillar B...
Blood Cancer Journal
comment
0
thumb_up
0
Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
Smoldering multiple myeloma (SMM) is a precursor plasma cell disorder charac...
Blood Cancer Journal
comment
0
thumb_up
0
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee
In March 2023 and 2024, a panel of international experts convened at the first and second Intercepting Blood Cancers (IBC)...
Blood Cancer Journal
comment
0
thumb_up
0
Clustering of lymphoid neoplasms by cell of origin, somatic mutation and drug usage profiles: a multi-trait genome-wide association study
Lymphoid neoplasms (LNs) are heterogeneous malignancies arising from lymphoid cells, displaying diverse clinical and molec...
Blood Cancer Journal
comment
0
thumb_up
0
Pediatric MDS in GATA2 deficiency, narrowing the scope
Kotmayer L, Kozyra EJ, Kang G, Strahm B, Yoshimi A, Sahoo SS, et al. Age-dependent phenotypic and molecular evolution of p...
Blood Cancer Journal
comment
0
thumb_up
0
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
Autologous stem cell transplantation (ASCT) is a key therapeutic strategy for many patients diagnosed with multiple myelom...
Blood Cancer Journal
comment
0
thumb_up
0
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Response and progression criteria are necessary for any malignancy to standa...
Blood Cancer Journal
comment
0
thumb_up
0
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
Accumulating evidence suggests that blinatumomab (a CD3-CD19 bispecific T-ce...
Blood Cancer Journal
comment
0
thumb_up
0
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases
Anemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...
Blood Cancer Journal
comment
0
thumb_up
0
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry
Despite the considerable effort to characterize the genomic landscape of chronic lymphocytic leukemia (CLL), published dat...
Blood Cancer Journal
comment
0
thumb_up
0
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
Patients with relapsed/refractory multiple myeloma (RRMM) have a poor prognosis and a need remains for novel effective the...
Blood Cancer Journal
comment
0
thumb_up
0
Defining ‘Intention’ in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4....
Blood Cancer Journal
comment
0
thumb_up
0
Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients
CBF-AMLs, which account for approximately 12–15% of all AML cases, involve c...
Blood Cancer Journal
comment
0
thumb_up
0
Correction: A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4....
Blood Cancer Journal
comment
0
thumb_up
0
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial
Given the early use of triplet and quadruplet regimens, most patients with multiple myeloma (MM) will be exposed and/or re...
Blood Cancer Journal
comment
0
thumb_up
1
Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma
Multiple myeloma (MM) is a hematological malignancy whose curability is greatly challenged by recurrent patient relapses a...
Blood Cancer Journal
comment
0
thumb_up
0
Bispecific antibodies in the treatment of multiple myeloma
The treatment paradigm in myeloma is constantly changing. Upfront use of monoclonal antibodies like daratumumab along with...
Blood Cancer Journal
comment
0
thumb_up
0
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma
First-line treatment for advanced-stage diffuse large B-cell lymphoma (DLBCL) typically involves 6x R-CHOP21 or 6x R-CHOP2...
Blood Cancer Journal
comment
0
thumb_up
0
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients
Lenalidomide, bortezomib, and dexamethasone (RVd) have previously been established as standard-of-care induction therapy f...
Blood Cancer Journal
comment
0
thumb_up
0
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, et al. Prognostic implication of FLT3 and N-RAS gene mutations ...
Blood Cancer Journal
comment
0
thumb_up
0
Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia
Begna KH, Xu X, Gangat N, Alkhateeb H, Patnaik MM, Al-Kali A, et al. Core-binding factor acute myeloid leukemia: long-term...
Blood Cancer Journal
comment
0
thumb_up
0
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy
Therapy-related acute myeloid leukemia (t-AML) often exhibits adverse (genetic) features. There is ongoing discussion on t...
Blood Cancer Journal
comment
0
thumb_up
0
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison
Competing interests MS reports receiving funding from BeiGene paid to Fred...
Blood Cancer Journal
comment
0
thumb_up
0
A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping
Multiple myeloma (MM) is a plasma cell neoplasm (PCN) [1]. Sensitive and accurate identification of g...
Blood Cancer Journal
comment
0
thumb_up
0
Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis
TP53 mutations (TP53Mut) define the most rapidly fatal AML subtype [1, 2] (Supplementary Fig. S1A). We used AML datasets (...
Blood Cancer Journal
comment
0
thumb_up
0
The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients
Nucleoporin 98 (NUP98, chromosome 11p15) fusion oncoproteins also called NUP98 rearrangements (NUP98r...
Blood Cancer Journal
comment
0
thumb_up
0
T cells with high BCL-2 expression induced by venetoclax impact anti-leukemic immunity “graft-versus-leukemia effects”
BCL-2, a crucial regulator of the mitochondrial apoptotic pathway, maintains myeloblast survival by s...
Blood Cancer Journal
comment
0
thumb_up
0
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
CAR-T cell therapy has led to a significant advance in the treatment of refractory/relapsed diffuse l...
Blood Cancer Journal
comment
0
thumb_up
0
Load More
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?
Or using
Linkedin